Upgrade to SI Premium - Free Trial

CVS Caremark (CVS) Tops Q2 EPS by 1c; Narrows FY Outlook

August 6, 2013 7:19 AM
CVS Caremark (NYSE: CVS) reported Q2 EPS of $0.97, $0.01 better than the analyst estimate of $0.96. Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Earnings Guidance Hot Earnings

Next Articles